{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:22:45Z","timestamp":1790871765803,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-05192-x","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T09:08:25Z","timestamp":1723453705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Alexandre","family":"Guigui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Aumatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Gondran-Tellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Uleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Long-Depaquit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Dinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio Dal","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Akiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-3873","authenticated-orcid":false,"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"issue":"1","key":"5192_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"2","key":"5192_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11934-012-0234-4","volume":"13","author":"M Ramirez-Backhaus","year":"2012","unstructured":"Ramirez-Backhaus M, Dominguez-Escrig J, Collado A, Rubio-Briones J, Solsona E (2012) Restaging transurethral resection of bladder tumor for high-risk stage Ta and T1 bladder cancer. Curr Urol Rep 13(2):109\u2013114","journal-title":"Curr Urol Rep"},{"issue":"4","key":"5192_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2018","unstructured":"Naselli A, Hurle R, Paparella S et al (2018) Role of Restaging Transurethral Resection for T1 non-muscle invasive bladder Cancer: a systematic review and Meta-analysis. Eur Urol Focus 4(4):558\u2013567","journal-title":"Eur Urol Focus"},{"issue":"2","key":"5192_CR4","first-page":"8198","volume":"23","author":"JR Gregg","year":"2016","unstructured":"Gregg JR, McCormick B, Wang L et al (2016) Short term complications from transurethral resection of bladder tumor. Can J Urol 23(2):8198\u20138203","journal-title":"Can J Urol"},{"issue":"10","key":"5192_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","volume":"38","author":"K Mori","year":"2020","unstructured":"Mori K, Miura N, Babjuk M et al (2020) Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review. Urol Oncol 38(10):774\u2013782","journal-title":"Urol Oncol"},{"key":"5192_CR6","unstructured":"Yanagisawa T, Kawada T, von Deimling M et al Repeat Transurethral Resection for non-muscle-invasive bladder Cancer: an updated systematic review and Meta-analysis in the contemporary era. Eur Urol Focus 2023 Jul 24:S2405-4569(23)00173-6."},{"issue":"6","key":"5192_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1464-410X.2006.06145.x","volume":"97","author":"HW Herr","year":"2006","unstructured":"Herr HW, Donat SM (2006) A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 97(6):1194\u20131198","journal-title":"BJU Int"},{"issue":"4","key":"5192_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V et al (2021) European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for Grade: an update from the EAU NMIBC guidelines Panel. Eur Urol 79(4):480\u2013488","journal-title":"Eur Urol"},{"issue":"9","key":"5192_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11934-016-0625-z","volume":"17","author":"R Veeratterapillay","year":"2016","unstructured":"Veeratterapillay R, Heer R, Johnson MI, Persad R, Bach C (2016) High-risk non-muscle-invasive bladder Cancer-Therapy options during Intravesical BCG shortage. Curr Urol Rep 17(9):68","journal-title":"Curr Urol Rep"},{"key":"5192_CR10","doi-asserted-by":"crossref","unstructured":"Verri P, Baboudjian M, Diana P et al (2023 Jan-Feb) Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis. Actas Urol Esp (Engl Ed), vol 47. English, Spanish, pp 4\u201314. 1","DOI":"10.1016\/j.acuroe.2022.08.005"},{"issue":"5","key":"5192_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/bju.15941","volume":"131","author":"Y Neuzillet","year":"2023","unstructured":"Neuzillet Y, Leon P, Seisen T et al (2023) A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer. BJU Int 131(5):611\u2013616","journal-title":"BJU Int"},{"key":"5192_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0022-5347(17)37779-0","volume":"146","author":"R Klan","year":"1991","unstructured":"Klan R, Loy V, Huland H (1991) Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146:316\u2013318","journal-title":"J Urol"},{"key":"5192_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00005392-199907000-00018","volume":"162","author":"HW Herr","year":"1999","unstructured":"Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162:74\u201376","journal-title":"J Urol"},{"key":"5192_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bju.13354","volume":"118","author":"P Gontero","year":"2016","unstructured":"Gontero P, Sylvester R, Pisano F et al (2016) The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/grade 3 bladder cancer treated with bacille Calmette-Guerin. BJU Int 118:44\u201352","journal-title":"BJU Int"},{"key":"5192_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","volume":"38","author":"JC Angulo","year":"2014","unstructured":"Angulo JC, Palou J, Garc\u0131a-Tello A, de Fata FR, Rodr\u0131guez O, Villavicencio H (2014) Second transurethral resection and prognosis of highgrade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guerin. Actas Urol Esp 38:164\u2013171","journal-title":"Actas Urol Esp"},{"key":"5192_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4081\/aiua.2016.2.81","volume":"88","author":"R Sanseverino","year":"2016","unstructured":"Sanseverino R, Napodano G, Campitelli A, Addesso M (2016) Prognostic impact of reTURB in high grade T1 primary bladder cancer. Arch Ital Urol Androl 88:81\u201385","journal-title":"Arch Ital Urol Androl"},{"issue":"7","key":"5192_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1089\/end.2020.1107","volume":"35","author":"A Tadrist","year":"2021","unstructured":"Tadrist A, Gondran-Tellier B, McManus R et al (2021) Primary complete transurethral resection of bladder tumor using photodynamic diagnosis for high-risk nonmuscle invasive bladder Cancer: is a restaging photodynamic transurethral resection really necessary? J Endourol 35(7):1042\u20131046","journal-title":"J Endourol"},{"issue":"2","key":"5192_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.urolonc.2022.10.026","volume":"41","author":"M Alsyouf","year":"2023","unstructured":"Alsyouf M, Ladi-Seyedian SS, Konety B et al (2023) Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? Urol Oncol 41(2):109.e9\u2013109.e14","journal-title":"Urol Oncol"},{"issue":"5","key":"5192_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euo.2023.07.010","volume":"6","author":"D D\u2019Andrea","year":"2023","unstructured":"D\u2019Andrea D, Soria F, Hurle R et al (2023) En Bloc Versus Conventional resection of primary bladder tumor (eBLOC): a prospective, Multicenter, Open-label, phase 3 Randomized Controlled Trial. Eur Urol Oncol 6(5):508\u2013515","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"5192_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R et al (2016) Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA\/SUO Guideline. J Urol 196(4):1021\u20131029","journal-title":"J Urol"},{"issue":"1","key":"5192_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","volume":"177","author":"HW Herr","year":"2007","unstructured":"Herr HW, Donat SM, Dalbagni G (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 177(1):75\u201379 discussion 79","journal-title":"J Urol"},{"issue":"10","key":"5192_CR22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00345-018-2299-2","volume":"36","author":"J Palou","year":"2018","unstructured":"Palou J, Pisano F, Sylvester R et al (2018) Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol 36(10):1621\u20131627","journal-title":"World J Urol"},{"key":"5192_CR23","unstructured":"Arnaud Q, Sebe P, Colau A et al Management of high-grade papillary Ta or T1 bladder cancer after restaging transurethral resection: a retrospective study comparing Bacillus Calmette-Guerin therapy upfront versus a third resection. Prog Urol 2023 Nov 16:S1166-7087(23)00238-5."}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05192-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T16:20:26Z","timestamp":1735834826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05192-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5192"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05192-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approve the submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication (include appropriate statements)"}},{"value":"The authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests (include appropriate disclosures)"}},{"value":"For this study design (i.e., retrospective study), ethical approval is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this study design (i.e., retrospective study), informed consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (include appropriate statements)"}},{"value":"The authors have nothing to disclose.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"480"}}